Navigation Links
Regeneron Named World's #1 Biopharmaceutical Employer in Science Magazine Annual Survey
Date:9/21/2012

TARRYTOWN, N.Y., Sept. 21, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that Science magazine has ranked Regeneron as the #1 employer in the global biopharmaceutical industry in the journal's annual Top Employers Survey.

"This recognition by Science as the most respected company to work for in the biopharmaceutical industry is very satisfying for all of us at Regeneron," said Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron Pharmaceuticals and George D. Yancopoulos, M.D., Ph.D., Chief Scientific Officer and President, Regeneron Laboratories.  "Since we opened our first lab in 1989, we have believed that innovative science could be harnessed to deliver important new medicines for serious conditions.  As we have grown from a handful of people to nearly 1,900 employees today, we have worked hard to maintain a culture that values rigorous science, creative thinking, and collegiality.  We are fortunate to have such talented employees who are dedicated to discovering and developing new treatments for patients in need."

This is the first year that Regeneron has captured the #1 position and the first time a New York based company has topped the survey.  Last year Regeneron was ranked #2.

The 2012 survey sought to identify the companies with the best reputations as employers, based on 4,276 survey responses from readers of Science and other survey invitees.  Survey participants came from North America (78%), Europe (14%), and Asia/Pacific Rim (5%); 93% worked in private industry.  Details of the rankings and survey results can be found in the September 21 online edition of Science and will be featured in the October 19, 2012 print issue.

On Monday, September 24, New York State Lt. Governor Robert Duffy and U.S. Congresswoman Nita Lowey and other public officials are scheduled to participate in an event with Regeneron's Tarrytown employees that will recognize this important achievement.

Separately, Regeneron announced another step to reinforce its commitment to science by launching a new Post-Doctoral Training Program that is accepting applications for its 2013 class.  The three-year multi-faceted program will integrate cutting edge science with didactic training, discussion groups, and focused mentoring.

About Regeneron Pharmaceuticals, Inc.  
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use; ZALTRAP is co-commercialized with Sanofi.  Regeneron has filed a regulatory application with the U.S. Food and Drug Administration (FDA) for a second indication for EYLEA.  Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727.  Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.  Additional information and recent news releases are available on the Regeneron web site at www.regeneron.com.

Contact Information:   
Peter Dworkin   
Corporate Communications  
914.847.7640  
peter.dworkin@regeneron.com

Manisha Narasimhan, Ph.D.  
Investor Relations    
914.847.5126    
manisha.narasimhan@regeneron.com


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Regeneron Announces September 2012 Investor Conference Presentations
2. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
3. Regeneron Announces June 2012 Investor Conference Presentations
4. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
5. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
6. Mersana Therapeutics Named a "Fierce 15" Biotech Company for 2012
7. Donor Alliance Named Colorados Top Healthcare Company
8. Millennium Laboratories Angela Huskey Named Industry Pain Educator of the Year by American Society of Pain Educators
9. Impact Advisors Named to Inc. 5000 List of Nations Fastest-Growing Companies
10. Ingenuity Systems Named 2013 World Economic Forum Technology Pioneer
11. Saddleback Memorial Named First Robotic Training Epicenter for Gynecologic Surgery in Orange County
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... ... Cataract is the world's leading cause of blindness , accounting for ... States, more than 25 million Americans are estimated to have cataract, according to the ... As the population in America continues to age, the number of cataract cases are ...
(Date:5/21/2020)... ... May 21, 2020 , ... Murrieta Genomics has partnered with ... Conference to offer startup companies a special discount rate to the Digital RESI ... series was created by LSN to bring together startups with early-stage investors and strategic ...
(Date:5/21/2020)... ... 21, 2020 , ... In celebration of Nurses Month, ... set of retail offers and recognized a dedicated group of backers—all collaborating to ... PPE units have arrived to hospitals through commercial, government, and charity efforts, hundreds ...
Breaking Medicine Technology:
(Date:5/21/2020)... ... 2020 , ... Friends of Lisa Campbell, announce that Lisa Campbell, candidate for ... Southeast Advocates (PPSEA). PPSEA educates and lobbies on behalf of women’s health ... reproductive health care. PPSEA educates and lobbies on behalf of women’s health and works ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ... its award-winning population health management platform that supports care management and utilization management ... 100 individuals at client sites, TruCare 2020 provides significant usability and automation upgrades ...
(Date:5/16/2020)... ... May 15, 2020 , ... For patients who have gone to see Andy Gaertner, ... office has always had in place. After being allowed to re-open during the current pandemic, ... and staff are as safe and comfortable as possible while going through their dental exams ...
(Date:5/15/2020)... ... May 15, 2020 , ... COVID-19 has made people feel fearful, but Rieke ... their employees can get back to work safely. Their unique line of SafeSpace™ PPE ... bars, and countless other settings. , Everyone needs to be able to get back ...
(Date:5/15/2020)... ... May 15, 2020 , ... As businesses prepare to reopen, ... There is a need to combat the spread of the virus in a way ... Touchrate hopes to help with their TempCheck Sentinel and TempCheckplus Sentry no-contact infrared temperature ...
Breaking Medicine News(10 mins):